Lars Tatenhorst
Impact in
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
-
- Nerve injury and regeneration
- Nuclear Receptors and Signaling
- Neuroscience and Neuropharmacology Research
Papers in
- Neurology 17
- Parkinson's Disease Mechanisms and Treatments 16
- Neurological disorders and treatments 6
- Botulinum Toxin and Related Neurological Disorders 4
-
- Nerve injury and regeneration 9
Lars Tatenhorst
31 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 109
- Neurology 250
- Neurology 435
- Cellular and Molecular Neuroscience 390
- Developmental Neuroscience 69
- Genetics 155
Countries citing papers authored by Lars Tatenhorst
This map shows the geographic impact of Lars Tatenhorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Tatenhorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Tatenhorst more than expected).
Fields of papers citing papers by Lars Tatenhorst
This network shows the impact of papers produced by Lars Tatenhorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Tatenhorst. The network helps show where Lars Tatenhorst may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lars Tatenhorst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 14 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 44 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 41 | |
| 7 | 2021 | 10 | |
| 8 | 2021 | 17 | |
| 9 | 2020 | 43 | |
| 10 | 2019 | 13 | |
| 11 | 2018 | 169 | |
| 12 | 2018 | 39 | |
| 13 | 2014 | 23 | |
| 14 | 2014 | 45 | |
| 15 | 2008 | 14 | |
| 16 | 2008 | 5 | |
| 17 | 2006 | 57 | |
| 18 | 2006 | 67 | |
| 19 | 2004 | 157 | |
| 20 | 2004 | 63 |
About Lars Tatenhorst
Lars Tatenhorst is a scholar working on Neurology, Cellular and Molecular Neuroscience, Neurology, Cancer Research and Immunology and Allergy, having authored 31 papers that have together received 1.5k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (16 papers), Nerve injury and regeneration (9 papers), Neurological disorders and treatments (6 papers), Botulinum Toxin and Related Neurological Disorders (4 papers), Alzheimer's disease research and treatments (4 papers), MicroRNA in disease regulation (3 papers), Autophagy in Disease and Therapy (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). The work is most often cited by research in Neurology (250 citations), Neurology (435 citations), Cellular and Molecular Neuroscience (390 citations), Developmental Neuroscience (69 citations) and Genetics (155 citations). Lars Tatenhorst has collaborated with scholars based in Germany, Bulgaria and Brazil. Frequent co-authors include Paul Lingor, Lars Tönges, Jan Christoph Koch, Mathias Bähr, Werner Paulus, Volker Senner, Kim‐Ann Saal, Anna‐Elisa Roser, Éva M. Szegő and Vivian Dambeck. Their work appears in journals such as Journal of Neurochemistry, Scientific Reports, Cell Death and Disease, PPAR Research and Brain Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.